Nektar Therapeutics (NKTR) Change in Cash (2010 - 2026)

Nektar Therapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at $134.5 million for Q1 2026.

• In Q1 2026, Change in Cash rose 2609.56% year-over-year to $134.5 million; the TTM figure through Mar 2026 stood at $110.7 million (up 1235.45% YoY), while the FY2025 annual figure was -$29.1 million, down 424.64% from the prior year.
• Change in Cash for Q1 2026 stood at $134.5 million, up from -$25.9 million in the prior quarter.
• The five-year high for Change in Cash was $134.5 million in Q1 2026, with the low at -$29.6 million in Q4 2023.
• The 5-year median for Change in Cash is $2.2 million (2024), against an average of $7.3 million.
• The sharpest annual moves came in 2023 and 2026: Change in Cash slumped 374.57% in 2023, then jumped 2609.56% in 2026.
• Nektar Therapeutics' Change in Cash stood at -$17.5 million in 2022, then tumbled by 69.09% to -$29.6 million in 2023, then soared by 147.71% to $14.1 million in 2024, then slumped by 283.24% to -$25.9 million in 2025, then jumped by 618.84% to $134.5 million in 2026.
• Business Quant data shows NKTR's Change in Cash at $134.5 million in Q1 2026, -$25.9 million in Q4 2025, and -$2.0 million in Q3 2025.